§ Sir Michael McNair-WilsonTo ask the Secretary of State for Health when he expects erythropoietin to be licensed for general use by the medical profession.
§ Mr. MellorFor reasons of commercial confidentiality, it is not usual practice to disclose information about whether or not an application for a product licence has been received or the progress of any such application. However in this case I am able to say that a few technical queries remain and are being urgently pursued; if they are satisfactorily resolved a licence should then be issued shortly.